Ouyang Lamei, Pan Yin, Wu Ya-Fei, Tang Qiang, Wang Dao-Feng, Lou Ning
Department of Critical Care Medicine, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, P. R, China.
The Affiliated Guangdong Second Provincial General Hospital of Jinan University China, Guangzhou, P. R. China.
Ren Fail. 2025 Dec;47(1):2443026. doi: 10.1080/0886022X.2024.2443026. Epub 2025 Jan 13.
Sepsis is an uncontrolled systemic response to infection that leads to life-threatening organ dysfunction. The in-hospital mortality rate remains significantly high in septic shock patients with malignancies. This study investigates whether early and high-volume administration of sodium bicarbonate during continuous renal replacement therapy (CRRT) can reduce 28-day mortality, increase shock reversal rates, and shorten the duration of CRRT, mechanical ventilation, and intensive care unit (ICU) stays. The goal is to provide valuable clinical data for the management of cancer patients with sepsis-associated acute kidney injury (SAKI).
A retrospective study was performed on 88 patients who were admitted to the ICU and received continuous renal replacement therapy (CRRT) for acute renal failure secondary to sepsis at the Cancer Center of Sun Yat-sen University from March 2010 to October 2021. Based on the initiation time of CRRT and the volume of sodium bicarbonate infusion, patients were divided into four groups: the early high-volume group, early low-volume group, late high-volume group, and late low-volume group.
The results of this study showed that in the 28-day mortality model, established using the Cox proportional hazards method, early CRRT (HR 0.473; 95% CI 0.245-0.915, = 0.026) and high-volume sodium bicarbonate infusion (HR 0.173; 95% CI 0.078-0.383, < 0.001) were identified as two independent protective factors. The 28-day mortality rate in the early high-volume group (15.0%) was significantly lower than that of the other three groups (60.0%, 30.0%, and 75.0%, respectively; = 23.822, < 0.001). Additionally, the shock reversal rate in the early high-volume group (80.0%) was significantly higher compared to the other groups (35.0%, 45.0%, and 35.7%; =13.576, = 0.004). The duration of CRRT was shorter in the early high-volume group (35.0 ± 4.45 h) than in the other groups (70.0 ± 30.19 h, 48.0 ± 5.22 h, and 72.0 ± 19.84 h; =11.278, = 0.01). Furthermore, the duration of mechanical ventilation (7.0 ± 3.33 days) was lower in the early high-volume group compared to the other groups (8.0 ± 1.12 days,10.0 ± 1.11 days, and 8.0 ± 2.65 days; =8.064, = 0.045), as was the length of ICU stay (7.0 ± 0.89 days) compared to the other groups (13.0 ± 3.35 days, 10.0 ± 1.49 days, and10.0 ± 3.70 days; = 9.184, = 0.027).
Early and high-volume administration of sodium bicarbonate during CRRT may reduce 28-day mortality and improve shock reversal rates in patients with sepsis-associated acute kidney injury complicated by malignancy. Prospective randomized controlled large sample studies are needed to confirm this.
脓毒症是对感染的一种不受控制的全身反应,可导致危及生命的器官功能障碍。恶性肿瘤合并感染性休克患者的院内死亡率仍然显著偏高。本研究调查了在持续肾脏替代治疗(CRRT)期间早期大量输注碳酸氢钠是否能降低28天死亡率、提高休克逆转率,并缩短CRRT、机械通气和重症监护病房(ICU)住院时间。目的是为癌症合并脓毒症相关性急性肾损伤(SAKI)患者的管理提供有价值的临床数据。
对2010年3月至2021年10月在中山大学肿瘤防治中心ICU住院并因脓毒症继发急性肾衰竭接受持续肾脏替代治疗(CRRT)的88例患者进行回顾性研究。根据CRRT开始时间和碳酸氢钠输注量,将患者分为四组:早期大量组、早期少量组、晚期大量组和晚期少量组。
本研究结果显示,在使用Cox比例风险法建立的28天死亡率模型中,早期CRRT(风险比0.473;95%置信区间0.245 - 0.915,P = 0.026)和大量输注碳酸氢钠(风险比0.173;95%置信区间0.078 - 0.383,P < 0.001)被确定为两个独立的保护因素。早期大量组的28天死亡率(15.0%)显著低于其他三组(分别为60.0%、30.0%和75.0%;P = 23.822,P < 0.001)。此外,早期大量组的休克逆转率(80.0%)显著高于其他组(35.0%、45.0%和35.7%;P = 13.576,P = 0.004)。早期大量组的CRRT持续时间(35.0 ± 4.45小时)短于其他组(70.0 ± 30.19小时、48.0 ± 5.22小时和72.0 ± 19.84小时;P = 11.278,P = 0.01)。此外,早期大量组的机械通气持续时间(7.0 ± 3.33天)低于其他组(8.0 ± 1.12天、10.0 ± 1.11天和8.0 ± 2.65天;P = 8.064,P = 0.045),ICU住院时间(7.0 ± 0.89天)也低于其他组(13.0 ± 3.35天、10.0 ± 1.49天和10.0 ± 3.70天;P = 9.184,P = 0.027)。
CRRT期间早期大量输注碳酸氢钠可能降低合并恶性肿瘤的脓毒症相关性急性肾损伤患者的28天死亡率并提高休克逆转率。需要进行前瞻性随机对照大样本研究来证实这一点。